Stonegate Investment Group LLC Has $443,000 Holdings in Haleon plc (NYSE:HLN)

Stonegate Investment Group LLC grew its holdings in shares of Haleon plc (NYSE:HLN) by 23.1% in the 4th quarter, Holdings Channel reports. The fund owned 46,428 shares of the company’s stock after buying an additional 8,720 shares during the period. Stonegate Investment Group LLC’s holdings in Haleon were worth $443,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Fortitude Family Office LLC acquired a new position in Haleon during the 3rd quarter worth approximately $28,000. Versant Capital Management Inc grew its stake in shares of Haleon by 2,029.1% during the fourth quarter. Versant Capital Management Inc now owns 3,513 shares of the company’s stock worth $34,000 after buying an additional 3,348 shares during the last quarter. Toronto Dominion Bank increased its holdings in shares of Haleon by 3,470.0% during the third quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock worth $38,000 after buying an additional 3,470 shares in the last quarter. Geneos Wealth Management Inc. bought a new position in shares of Haleon in the 4th quarter valued at $35,000. Finally, Prospera Private Wealth LLC acquired a new stake in shares of Haleon during the 3rd quarter valued at $57,000. Institutional investors own 6.67% of the company’s stock.

Wall Street Analysts Forecast Growth

HLN has been the subject of several research reports. Sanford C. Bernstein downgraded Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th. UBS Group upgraded shares of Haleon to a “strong-buy” rating in a report on Tuesday, October 1st. Finally, Morgan Stanley lowered shares of Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday, January 10th. Three research analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $10.95.

Haleon Trading Down 0.8 %

NYSE HLN opened at $9.51 on Wednesday. The firm has a market capitalization of $43.03 billion, a PE ratio of 27.96, a price-to-earnings-growth ratio of 2.60 and a beta of 0.29. The business’s 50-day moving average price is $9.54 and its two-hundred day moving average price is $9.75. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. Haleon plc has a 12 month low of $7.89 and a 12 month high of $10.80.

Haleon (NYSE:HLN) last announced its earnings results on Thursday, October 31st. The company reported $0.14 EPS for the quarter, beating the consensus estimate of $0.11 by $0.03. Haleon had a return on equity of 14.76% and a net margin of 10.85%. The business had revenue of $3.62 billion for the quarter, compared to analysts’ expectations of $3.74 billion. During the same period in the prior year, the business posted $0.10 earnings per share. On average, analysts expect that Haleon plc will post 0.44 EPS for the current year.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.